Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma
Epithelial Ovarian Carcinoma - Figo Stage IIIC
Conditions: official terms
Carcinoma - Neoplasms, Glandular and Epithelial - Ovarian Neoplasms
Conditions: Keywords
previous treatment surgery + 6 cycles of platinum based chemotherapy
Study Type
Study Phase
Phase 2
Study Design
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Name: hyper thermic chemo + surgery
Type: Procedure
Overall Status
Phase II to study results and morbidity of intra peritoneal hyper-thermic chemotherapy as consolidation therapy in patients with FIGO stage IIIC epithelial ovarian carcinoma treated by surgery and a total of 6 cycles of platinum based chemotherapy.

A second look operation is performed after treatment; during this second look secondary cytoreductive surgery is accepted without bowel resection.If none or milimetric peritoneal disease is obseved an intraperitoneal chemotherapy is achieve
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 65 Years
Minimum Age: 18 Years
Gender: Female
Criteria: Inclusion Criteria:

epithelial ovarian carcinoma previous surgery + 6 cycles platinum based chemotherapy


Exclusion Criteria:

- Patients ASA 3 patients with no residual tumor at first operation negative microscopic second look
Institut Gustave Roussy
Villejuif, France
Status: Recruiting
Contact: Dominique ELIAS, MD,PhD - 00 33 014-211-5441 -
Start Date
September 2004
Gustave Roussy, Cancer Campus, Grand Paris
Gustave Roussy, Cancer Campus, Grand Paris
Record processing date processed this data on July 28, 2015 page